Innodem Neurosciences: Clinical Trials

7 trials sponsored by Innodem Neurosciences, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 recruiting, 1 unknown. .

Follow Innodem Neurosciences: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
Eye-Tracking - Multiple Sclerosis
CompletedInnodem Neurosciences2002024-03-182026-04-01
ETNA-MS Device Validation Study
Eye-Tracking - Multiple Sclerosis
CompletedInnodem Neurosciences602023-12-122026-04-01
Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
Eye-Tracking - Multiple Sclerosis
CompletedInnodem Neurosciences1202023-08-162026-04-01
Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis
Eye-tracking - Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis
UnknownMcGill University1202022-09-012023-11-09
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
Eye-tracking - Neurological Disorders
TerminatedInnodem Neurosciences3002022-04-152026-04-06
Development and Validation of a Novel Functional Eye-Tracking Software Application for Cancer-related Cognitive Impairment (CRCI)
Eye-Tracking - Cancer-related Cognitive Impairment
TerminatedInnodem Neurosciences2302022-03-302026-04-06
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
Eye-Tracking - Multiple Sclerosis
RecruitingInnodem Neurosciences1682021-10-182026-04-01

Conditions studied

Multiple Sclerosis (5)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Nervous System Diseases (1)

Interventions

Eye-Tracking Technology (7)

Countries

Canada (6)  ·  United States (1)

Top investigators

Paul S Giacomini, MD (1)